OpportunityTitle: Paul Calabresi Career Development Award For Clinical Oncology (K12)
AdditionalInformationOnEligibility: Foreign institutions are not eligible to apply. All clinician and basic science Ph.D. scholars must satisfy the following additional requirements: Special Requirements Other training programs:  Where there already exists an active Ruth L. Kirschstein (T32) National Research Service Award (NRSA) or other institutional career development program (e.g., NCI and NIH Roadmap K12, K30, General Clinical Research Core [GCRC] Scholars Program) overlap between these programs must be eliminated and/or the NCI Paul Calabresi Award for Clinical Oncology (K12) structured in a way to complement and take advantage of these other career development/training programs.  This may require merging components of other programs with the NCI K12 or linking curriculum programs (e.g., K30) with the core requirements of the NCI K12.       Institutions require NCI approval to submit an application if another NCI K12 exists at the institution.   Institution: The institution must have substantial support for peer-reviewed basic science and clinical research and an adequate number of faculty qualified in patient-oriented therapeutic research, translational research, and basic science cancer research to serve as mentors in the proposed Program.   Environment: The research environment should be one in which there are active basic science/clinical research collaborations that exemplify a dynamic two-way exchange of information and ideas between basic science research and clinical scientists.   Special Program Requirements    Program Management: The PI must use an Advisory Committee (AC) to provide an oversight function and annual evaluation of the Program as a whole.  The committee&apos;s responsibilities should include but are not limited to: selecting clinician, nurse, and basic science scholars (Note: basic science scholars are encouraged as part of these Programs but they are optional), assigning preceptors, approving each scholar&apos;s career development plan, evaluating each scholar&apos;s progress, authorizing the termination of a scholar who is not performing adequately, monitoring the overall effectiveness of the program and recommending mid-course changes when needed.  A detailed description of the committee&apos;s composition, function, and frequency of meetings should be provided.    See Program Announcement for more information.
Description: -The goal of the Paul Calabresi Award for Clinical Oncology (PCACO) is to ensure a cadre of medical doctors and basic science researchers who can collaborate with each other to design and implement hypothesis-based translational therapeutic research. -The purpose of the PCACO is to increase the number of medical doctors (M.D. s, D.O. s), and doctorally-degreed nurses (Ph.D. s or equivalents) and basic research scientists (Ph.D. s, D.V.M. s, or equivalents) who are highly-motivated and trained to: 1) primarily perform clinical oncology therapeutic research that develops and tests scientific hypotheses based on fundamental and clinical research findings; 2) design and test hypothesis-based, clinical therapeutic protocols and adjunct biological analyses and for clinician candidates to administer all phases (i.e., pilot/Phase I, Phase II, and Phase III) of cancer therapeutic clinical trials, and (3) conduct cancer therapeutic research in team research settings in which basic research and clinical scientists collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will emphasize the use of animal or other model systems. -The PCACO application may be submitted on behalf of the program leader (principal investigator or PI) by for-profit or non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; and domestic institutions or organizations. Foreign institutions are not eligible to apply.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV
CloseDateExplanation: Multiple Receipt Dates - See Link to Full Announcement for details.